Measles virus plays key role in Paget’s disease of bone
January 15th, 2011 - 3:06 pm ICT by ANIWashington, Jan 15 (ANI): A team of researchers, led by the University of Pittsburgh School of Medicine, have found that a gene from the measles virus plays a key role in the development of Paget’s disease of bone.
Their findings confirm a long-held speculation that the childhood infection is an environmental trigger for the disease and reveal how the viral gene contributes to the development of its characteristic bone lesions.
“Our earlier work showed that bone cells called osteoclasts in about 70 percent of these patients contain a certain measles virus protein,” noted senior investigator, G. David Roodman, professor and vice chair for research, Department of Medicine.
“Also, when we engineered normal osteoclasts in mice to contain, or express, the measles protein, pagetic bone lesions formed.”
Osteoclast abnormalities lead to imbalance in the normal processes of bone dissolution and rebuilding. Bones are enlarged but fragile, leading to pain and a greater likelihood of fracture. Arthritis, hearing loss and kidney stones can occur.
In the new study, Roodman’s team sought to understand the roles of mutations in a gene called p62, which is common among PD patients, and measles virus nucleocapsid protein (MVNP) by examining the marrow of affected and unaffected bones of 12 PD patients and of eight people without PD. They also bred mice with the p62 mutation and MVNP.
The team found that marrow from eight of the 12 PD patients expressed MVNP; three patients expressed the protein in both affected and unaffected bone sites, and four patients did not make it at either type of site. Osteoclast precursor cells from PD patients who made MVNP formed pagetic osteoclasts in test tube experiments and displayed other typical PD responses. Osteoclasts appeared normal, though, when the precursor cells came from PD patients who didn’t make MVNP.
Mice with a p62 gene mutation and MVNP developed dramatic bone lesions. Other tests indicate that the presence of MVNP increases production of the cell-signaling protein interleukin-6, which in turn leads to osteoclast changes that are seen in PD.
The study was recently published in Cell Metabolism. (ANI)
- Mouse genome offers human cancer clue - Mar 24, 2011
- Protein behind Alzheimer's patients loss of smell? - Sep 29, 2011
- 'Key player' that facilitates Parkinson's disease found - Mar 04, 2011
- Rare disease 'paves way for creating stem cells' - Nov 22, 2010
- How sickle haemoglobin protects against malaria - Apr 29, 2011
- Factor boosting leukemia's aggressiveness identified - Oct 23, 2010
- Immune system can abort stem cell regeneration - Nov 21, 2011
- Bone marrow cells that convert into skin cells could revolutionise wound treatment - Apr 05, 2011
- Fish oil may hold key to leukaemia cure - Dec 23, 2011
- 'Longevity' protein may ward off precursor to prostate cancer - Jan 14, 2011
- New gene could trigger osteoporosis - Oct 05, 2011
- Discovery on measles could spur less toxic cancer cure - Nov 06, 2011
- Measles virus is 'the latest weapon against cancer' - Jan 13, 2011
- Gene that can influence a person's risk for developing epilepsy identified - Apr 05, 2011
- Gene discovery offers hope of screening test for bone disease - May 03, 2010
Tags: bone cells, bone lesions, childhood infection, dissolution, fracture, gene mutation, hearing loss, key role, kidney stones, measles, paget s disease, pd patients, pittsburgh school, precursor cells, school of medicine, test tube experiments, university of pittsburgh school of medicine, vice chair, viral gene, virus protein